A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conv...
A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer
About this item
Full title
Author / Creator
Yokota, Tomoya , Kato, Ken , Hamamoto, Yasuo , Tsubosa, Yasuhiro , Ogawa, Hirofumi , Ito, Yoshinori , Hara, Hiroki , Ura, Takashi , Kojima, Takashi , Chin, Keisho , Hironaka, Shuichi , Kii, Takayuki , Kojima, Yasushi , Akutsu, Yasunori , Matsushita, Hisayuki , Kawakami, Kentaro , Mori, Keita , Makiuchi, Takashi , Nagumo, Rie and Kitagawa, Yuko
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
A multicenter phase 2 trial analysed chemoselection with docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy (ICT) and subsequent conversion surgery (CS) for locally advanced unresectable esophageal cancer. This study presents updated 3-year analyses to further characterize the impact of DCF-ICT followed by CS.
Alternative Titles
Full title
A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer
Authors, Artists and Contributors
Author / Creator
Kato, Ken
Hamamoto, Yasuo
Tsubosa, Yasuhiro
Ogawa, Hirofumi
Ito, Yoshinori
Hara, Hiroki
Ura, Takashi
Kojima, Takashi
Chin, Keisho
Hironaka, Shuichi
Kii, Takayuki
Kojima, Yasushi
Akutsu, Yasunori
Matsushita, Hisayuki
Kawakami, Kentaro
Mori, Keita
Makiuchi, Takashi
Nagumo, Rie
Kitagawa, Yuko
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2267997955
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2267997955
Other Identifiers
ISSN
1068-9265
E-ISSN
1534-4681
DOI
10.1245/s10434-019-07654-8
